simvastatin has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bumbasirevic, V; Ciric, D; Kravic-Stevovic, T; Martinovic, T; Petricevic, S; Trajkovic, V | 1 |
| Arias-Carvajal, O; Cardona-Muñoz, EG; Miranda-Díaz, AG; Moreno-Ulloa, A; Pacheco-Moisés, FP; Rodríguez-Carrizalez, AD; Román-Pintos, LM; Troyo-Sanromán, R; Villegas-Rivera, G | 1 |
1 trial(s) available for simvastatin and Diabetic Neuropathies
| Article | Year |
|---|---|
Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Topics: Diabetic Neuropathies; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rosuvastatin Calcium; Simvastatin | 2015 |
1 other study(ies) available for simvastatin and Diabetic Neuropathies
| Article | Year |
|---|---|
Metformin exacerbates and simvastatin attenuates myelin damage in high fat diet-fed C57BL/6 J mice.
Topics: Animals; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diet, High-Fat; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Mice; Mice, Inbred C57BL; Myelin Sheath; Sciatic Nerve; Simvastatin | 2018 |